EPS Creative Health Technology Group Limited Mr. Gao Feng ("Mr. Gao"), an executive Director, has been re-designated from Chief Executive Officer to Chief Strategy Officer of the Company; Mr. Okoso, now an executive Director, has been appointed as the Chief Executive Officer. Following the above changes, Mr. Okoso will be both the chairman of the Board and the Chief Executive Officer of the Company. Mr. Okoso is an executive officer of EPS Japan and has over 35 years of experience in clinical research, pharmacoepidemiology and healthcare industry.

He has been the chairman of the Board since 30 June 2021. As Mr. Gao, the former Chief Executive Officer has been redesignated to his new role of Chief Strategy Officer of the Company, Mr. Okoso, who has many years of experience in senior management positions, has taken up the role of Chief Executive Officer of the Company. The Directors consider that vesting the roles of the chairman of the Board and the Chief Executive Officer of the Company in Mr. Okoso is beneficial to the management and the business developments of the Group and will provide a strong and consistent leadership to the Group.

The Board will continue to review and consider splitting the roles of the chairman of the Board and the Chief Executive Officer of the Company as and when appropriate and suitable by taking into account the circumstances of the Group as a whole.